IMab (IMAB)
(Delayed Data from NSDQ)
$1.66 USD
-0.08 (-4.60%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.66 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for IMab Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 322 | 514 | 671 | 734 | 176 |
Receivables | 0 | 0 | 5 | 20 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 4 | 0 | 0 |
Other Current Assets | 7 | 12 | 70 | 65 | 20 |
Total Current Assets | 329 | 526 | 750 | 819 | 196 |
Net Property & Equipment | 5 | 9 | 7 | 4 | 4 |
Investments & Advances | 2 | 4 | 55 | 102 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 17 | 41 | 44 | 43 | 45 |
Deposits & Other Assets | 9 | 2 | 4 | 0 | 3 |
Total Assets | 368 | 591 | 879 | 971 | 250 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 0 | 0 | 0 | 0 | 0 |
Current Portion Long-Term Debt | 4 | 3 | 0 | 0 | 7 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 51 | 104 | 93 | 87 | 39 |
Total Current Liabilities | 58 | 110 | 98 | 88 | 47 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 10 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 65 | 54 | 53 | 19 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 126 | 169 | 163 | 108 | 59 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,381 | 1,389 | 1,428 | 1,180 | 539 |
Retained Earnings | -1,173 | -995 | -683 | -310 | -358 |
Other Equity | 42 | 31 | -29 | -8 | 10 |
Treasury Stock | 8 | 3 | 0 | 0 | 0 |
Total Shareholder's Equity | 242 | 422 | 716 | 862 | 191 |
Total Liabilities & Shareholder's Equity | 368 | 591 | 879 | 971 | 250 |
Total Common Equity | 242 | 422 | 716 | 862 | 191 |
Shares Outstanding | 82.60 | 83.10 | 79.90 | 57.00 | 57.00 |
Book Value Per Share | 2.93 | 5.08 | 8.95 | 15.13 | 3.35 |
Fiscal Year End for IMab Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 322 | -99,999 | 410 | -99,999 |
Receivables | NA | 0 | NA | NA | NA |
Notes Receivable | NA | 0 | NA | NA | NA |
Inventories | NA | 0 | NA | NA | NA |
Other Current Assets | NA | 7 | NA | 14 | NA |
Total Current Assets | NA | 329 | NA | 424 | NA |
Net Property & Equipment | NA | 5 | NA | 7 | NA |
Investments & Advances | NA | 2 | NA | 2 | NA |
Other Non-Current Assets | NA | 0 | NA | NA | NA |
Deferred Charges | NA | 0 | NA | NA | NA |
Intangibles | NA | 17 | NA | 39 | NA |
Deposits & Other Assets | NA | 9 | NA | 6 | NA |
Total Assets | NA | 368 | NA | 484 | NA |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | NA | NA | NA |
Accounts Payable | NA | 0 | NA | NA | NA |
Current Portion Long-Term Debt | NA | 4 | NA | 4 | NA |
Current Portion Capital Leases | NA | 0 | NA | NA | NA |
Accrued Expenses | NA | 0 | NA | NA | NA |
Income Taxes Payable | NA | 0 | NA | NA | NA |
Other Current Liabilities | NA | 51 | NA | 84 | NA |
Total Current Liabilities | NA | 58 | NA | 91 | NA |
Mortgages | NA | 0 | NA | NA | NA |
Deferred Taxes/Income | NA | 0 | NA | NA | NA |
Convertible Debt | NA | 0 | NA | NA | NA |
Long-Term Debt | NA | 0 | NA | NA | NA |
Non-Current Capital Leases | NA | 0 | NA | NA | NA |
Other Non-Current Liabilities | NA | NA | 53 | NA | |
Minority Interest (Liabilities) | NA | 0 | NA | NA | NA |
Total Liabilities | NA | 126 | NA | 147 | NA |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | NA | NA | NA |
Common Stock (Par) | NA | 0 | NA | 0 | NA |
Capital Surplus | NA | 1,381 | NA | 1,345 | NA |
Retained Earnings | NA | -1,173 | NA | -1,053 | NA |
Other Equity | NA | 42 | NA | 52 | NA |
Treasury Stock | NA | 8 | NA | 6 | NA |
Total Shareholder's Equity | NA | 242 | NA | 337 | NA |
Total Liabilities & Shareholder's Equity | NA | 368 | NA | 484 | NA |
Total Common Equity | 0 | 242 | 0 | 100,336 | 0 |
Shares Outstanding | 80.80 | 82.60 | 82.60 | 82.90 | 83.10 |
Book Value Per Share | 0.00 | 2.93 | 0.00 | 1,210.33 | 0.00 |